argenx to acquire Unnatural Products to broaden immunology capabilities
FROM THE WIRE · FINANCE.YAHOO.COM
argenx SE Pairs Unnatural Products' (UNP) peptide expertise with argenx's antibody engineering, expanding the ways to target novel biology Extends argenx's immunology innovation to more patients, with the potential for oral and long-acting medicines Builds on more than two years…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralA targeted acquisition of a peptide discovery platform that extends argenx's immunology portfolio.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01argenx has signed a definitive agreement to acquire Unnatural Products, Inc.
- 02argenx already holds a minority stake in UNP and will acquire the remaining shares.
- 03The transaction values UNP at up to approximately $1.15 billion.
- 04UNP will continue operating from Santa Cruz, California, with its current team.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets